Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received June 29, 2020
- Accepted November 5, 2020
- Published online November 19, 2020.
Article Versions
- You are currently viewing a previous version of this article (November 19, 2020 - 07:26).
- View the most recent version of this article
Copyright & Usage
Copyright ©ERS 2020 This version is distributed under the terms of the Creative Commons Attribution Licence 4.0.
Author Information
- Nikhil Hirani1⇑,
- Alison C. MacKinnon1,2,
- Lisa Nicol1,
- Paul Ford2,
- Hans Schambye2,
- Anders Pedersen2,
- Ulf J. Nilsson3,
- Hakon Leffler4,
- Tariq Sethi2,
- Susan Tantawi2,
- Lise Gavelle2,
- Robert J. Slack2,
- Ross Mills1,
- Utsa Karmakar1,
- Duncan Humphries1,
- Fredrik Zetterberg2,
- Lucy Keeling5,
- Lyn Paul6,
- Philip L. Molyneaux6,
- Feng Li1,
- Wendy Funston7,
- Ian A. Forrest8,
- A. John Simpson7,8,
- Michael A. Gibbons9 and
- Toby M. Maher6,10
- 1MRC Centre for Inflammation Research, The Queen's Medical Research Institute University of Edinburgh, Edinburgh, UK
- 2Galecto, Inc., Copenhagen N, Denmark
- 3Department of Chemistry, Lund University, Lund, Sweden
- 4Department of Laboratory Medicine, Lund University, Lund, Sweden
- 5Exploristics, Belfast, UK
- 6National Institute for Health Research Respiratory Clinical Research Facility, Royal Brompton and Harefield NHS Foundation Trust, and Fibrosis Research Group, National Heart and Lung Institute, Imperial College, London, UK
- 7Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK
- 8Respiratory Medicine Unit, Royal Victoria Infirmary, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
- 9Respiratory Department Royal Devon and Exeter NHS Foundation Trust Exeter, Institute of Biomedical and Clinical Science University of Exeter Medical School Exeter, Exeter, UK
- 10Keck School of Medicine at University of Southern California, Los Angeles, California, USA
- Nikhil Hirani. E-mail: n.hirani{at}ed.ac.uk
Funding
Galecto Inc
Industry funding
Article usage
Altmetrics
Vol 62 Issue 3
Table of Contents
Target-inhibition of Galectin-3 by Inhaled TD139 in Patients with Idiopathic Pulmonary Fibrosis
